Blood Disorders Flashcards
(50 cards)
1
Q
Types of clots
A
492
2
Q
Coagulation cascade
A
493
3
Q
Drug treatment in clots
A
494
4
Q
Key points of anticoagulants
A
494
5
Q
Bleeding types and causes
A
495
6
Q
Unfractionated heparin
A
496
7
Q
Low molecular weight heparins (LMWH)
A
497
8
Q
Heparin-induced thrombocytopenia (HIT)
A
498
9
Q
Factor Xa inhibitors and dosing
A
499
10
Q
Factor Xa inhibitors safety, side effects monitoring
A
499
11
Q
Factor Xa drug interactions
A
500
12
Q
Conversions between anticoagulants
A
500
13
Q
Oral direct thrombin inhibitors
A
501
14
Q
Injectable direct thrombin inhibitors
A
501
15
Q
Warfarin
A
502
16
Q
Warfarin drug interactions
A
502/503
17
Q
Foods high in vitamin K
A
503
18
Q
Warfarin tablet colors
A
503
19
Q
Antidotes for reversal
A
504/505/506
20
Q
Risk factors for VTE
A
507
21
Q
Treatment of VTE
A
507
22
Q
AF anticoagulation with cardioversion
A
508
23
Q
CHA2DS2-VASc
A
508
24
Q
HAS-BLED
A
508
25
Anticoagulation in pregnancy
509
26
Key counseling points for anticoagulation
509
27
Symptoms of anemia
510
28
Types of anemia
511
29
Common lab tests in anemia
511
30
Causes of iron deficiency anemia
511
31
Assessment and treatment of iron deficiency anemia
512
32
Elemental iron in products
512
33
Oral iron products
512
34
Parenteral iron products
513
35
Macrocytic anemia diagnosis
514
36
Treatment of macrocytic anemia
514
37
Normocytic anemia pathophysiology
515
38
Erythropoiesis-stimulating agents
515
39
Drug-induced hemolytic anemia pathophysiology
516
40
Select drugs that cause hemolytic anemia
516
41
Key counseling points for anemia
516
42
Sickle cell disease pathophysiology
517/518
43
Sickle cell complications
518
44
Non drug treatment of sickle cell
518
45
Key vaccines in sickle cell
518
46
Hydroxyurea
519
47
L-glutamine
520
48
Voxelotor
520
49
Crizanlizumab
520
50
Key counseling points in sickle cell disease
521
